DOI QR코드

DOI QR Code

Analysis of Application of Massive Transfusion Protocol for Trauma Patients at a Single Tertiary Referral Hospital

단일 3차 의료기관에서 외상환자에 대한 대량수혈 프로토콜 적용 분석

  • Kim, Hyerin (Department of Laboratory Medicine, Pusan National University Hospital) ;
  • Yoo, Dong-Won (Department of Laboratory Medicine, Pusan National University Yangsan Hospital) ;
  • Kim, Hyerim (Department of Laboratory Medicine, Pusan National University Hospital) ;
  • Shin, Kyung-Hwa (Department of Laboratory Medicine, Pusan National University Hospital) ;
  • Lee, Hyun-Ji (Department of Laboratory Medicine, Pusan National University Yangsan Hospital) ;
  • Chang, Chulhun L. (Department of Laboratory Medicine, Pusan National University Yangsan Hospital) ;
  • Kim, Hyung-Hoi (Department of Laboratory Medicine, Pusan National University Hospital)
  • 김혜린 (부산대학교병원 진단검사의학과) ;
  • 유동원 (양산부산대학교병원 진단검사의학과) ;
  • 김혜림 (부산대학교병원 진단검사의학과) ;
  • 신경화 (부산대학교병원 진단검사의학과) ;
  • 이현지 (양산부산대학교병원 진단검사의학과) ;
  • 장철훈 (양산부산대학교병원 진단검사의학과) ;
  • 김형회 (부산대학교병원 진단검사의학과)
  • Received : 2018.10.15
  • Accepted : 2018.11.21
  • Published : 2018.12.31

Abstract

Background: Massive hemorrhage due to trauma is one of the major causes of death in trauma patients, and the quick supply of appropriate blood products is critical in order to reduce the mortality rate. We introduced a massive transfusion protocol (MTP) for safe and rapid transfusion of trauma patients. Using records collected since its adoption, we compared the characteristics of MTP applied group (MTP group) and MTP not applied group (non-MTP group) to determine whether there is an indicator for predicting patients to be treated with MTP. Methods: We retrospectively reviewed the electronic medical records and laboratory findings of patients who received massive transfusions in the trauma emergency room of a single tertiary hospital from February to August 2018. We analyzed various laboratory test results, the amount and ratio of the transfused blood products, and the time required for blood products to be released for the MTP group and the non-MTP group. Results: Of the 54 trauma patients who received massive transfusions, 31 were in the MTP group and 22 in the non-MTP group. There was no significant difference in initial vital signs (except blood pressure) and laboratory test results. Also there was no difference in the amount and ratio of blood products, but the time required for blood product release was shorter in the MTP group. Conclusion: There was no significant difference in clinical findings such as initial vital signs and laboratory test results between the MTP and non-MTP groups, but required blood products were prepared and released more quickly for the MTP group.

배경: 외상에 의한 대량출혈은 외상 환자의 주요 사망 원인 중 하나이며, 이 경우 초기에 다량의혈액제제를 적절한 비율로 신속하게 공급하는 것이 외상성 출혈로 인한 사망률을 감소시킨다는 점에서 매우 중요하다. 본 연구에서는 외상 환자에 대한 대량수혈을 보다 안전하고 신속하게 수행하기 위해 마련한 대량수혈 프로토콜(MTP)을 도입한 이후, MTP 적용군과 비적용군의 특성을 비교 분석하여 MTP를 적용할 환자를 예측하는데 도움을 줄 수 있는 임상적 지표가 있는지, MTP를 적용할 경우 보다 신속한 수혈이 가능한지를 확인하였다. 방법: 2018년 2월부터 8월까지 7개월간 단일 3차의료기관의 외상응급실을 통해 입원한 환자들 중 대량수혈을 받은 환자들의 전자의무기록 및 검사결과를 후향적으로 분석하였다. 대량수혈 환자는 초기 24시간 이내에 적혈구제제 10단위 이상을 수혈받은 16세 이상의 환자로 정의하였으며, 이들 중 MTP를 적용받은 군(MTP군)과 비적용군(non-MTP군)을 구분하여 수상 종류 및 메커니즘, 초기 활력징후, 혈액검사결과, 외상 중증도 평가 점수, 수혈된 혈액제제의 비율과 양, 혈액제제가 처방된 시점부터 출고되기까지 소요된 시간을 비교 분석하였다. 결과: 2018년 2월부터 8월까지 7개월간 대량수혈을 받은 53명의 외상환자들 중 MTP군은 31명, non-MTP군은 22명으로 확인되었으며, 수축기혈압 및 이완기혈압을 제외한 초기활력징후 및 초기 혈액검사결과는 두 군간 유의한 차이가 없었다. 두 군의 혈액제제 사용량 및 비율 또한 큰 차이가 없었으나, 혈액제제 출고 소요시간의 경우 non-MTP군보다 MTP군에서 더 짧은 것이 확인되었다. 결론: MTP군과 non-MTP군의 초기활력징후 및 검사결과 등 임상적 특성은 큰 차이를 보이지 않았으나, MTP군에서 혈액제제가 출고되기까지 소요되는 시간이 더 짧아 보다 신속하게 수혈을 시작할 수 있었다.

Keywords

References

  1. Evans JA, van Wessem KJ, McDougall D, Lee KA, Lyons T, Balogh ZJ. Epidemiology of traumatic deaths: comprehensive populationbased assessment. World J Surg 2010;34:158-63 https://doi.org/10.1007/s00268-009-0266-1
  2. Yucel N, Lefering R, Maegele M, Vorweg M, Tjardes T, Ruchholtz S, et al. Trauma Associated Severe Hemorrhage (TASH)-score: probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma. J Trauma 2006;60:1228-36; discussion 1236-7 https://doi.org/10.1097/01.ta.0000220386.84012.bf
  3. Malone DL, Hess JR, Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 2006;60(6 Suppl):S91-6 https://doi.org/10.1097/01.ta.0000199549.80731.e6
  4. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007;62:307-10 https://doi.org/10.1097/TA.0b013e3180324124
  5. Fung MK, Grossman BJ, Hillyer CD, Westhoff CM. Technical manual. 18th ed. Bethesda, Maryland: American Association of Blood Banks, 2014:645-61
  6. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007;63:805-13 https://doi.org/10.1097/TA.0b013e3181271ba3
  7. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. The European guideline on management of major bleeding and coagulopathy following trauma. Crit Care 2016;20:100 https://doi.org/10.1186/s13054-016-1265-x
  8. Dente CJ, Shaz BH, Nicholas JM, Harris RS, Wyrzykowski AD, Patel S, et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma 2009;66:1616-24 https://doi.org/10.1097/TA.0b013e3181a59ad5
  9. Koo HS, Ahn YS, Park JW, Lee HM. Physicians' attitudes and knowledge concerning antibiotics prescription and resistance in Korea. Public Health Wkly Rep 2018;11:772-9
  10. Choi GR, Choi SJ, Kim SY, Kim HO. An analytical study for cases associated with massive blood transfusion at a tertiary referral hospital. Korean J Blood Transfus 2014;25:123-31
  11. The Korean Society of Blood Transfusion. Transfusion guideline. 4th ed. http://www.transfusion.or.kr/file/4_file01.pdf [Online] (last visited on 10 September 2018)
  12. Patil V, Shetmahajan M. Massive transfusion and massive transfusion protocol. Indian J of Anaesth 2014;58:590-5 https://doi.org/10.4103/0019-5049.144662
  13. Lee HT, Par PW, Seo YH, Ahn JY, Seo JY, Jeong JH, et al. Massive transfusion protocols for pediatric patients. Lab Med Online 2016;6:60-3 https://doi.org/10.3343/lmo.2016.6.2.60
  14. Cotton BA, Gunter OL, Isbell J, Au BK, Robertson AM, Morris JA Jr, et al. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008;64:1177-82; discussion 1182-3 https://doi.org/10.1097/TA.0b013e31816c5c80
  15. Kim HR, Yoo DW, Shin KW, Lee HJ, Kim HH. Analysis of massive transfusion for trauma patients and non-trauma patients in a tertiary hospital. Korean J Blood Transfus 2016;27:237-46 https://doi.org/10.17945/kjbt.2016.27.3.237
  16. Yoo DW, Kim H, Shin KH, Lee HJ, Chang CH, Kim HH. Comparative analytical study on massive transfusion between traumatic emergency and existing emergency rooms for traumatic patients at a tertiary hospital. Korean J Blood Transfus 2017;28:248-55 https://doi.org/10.17945/kjbt.2017.28.3.248
  17. Ahn E, Choi SH, Kim JY, Park JH, Cho YD. Analysis of trauma patients with massive transfusion in the emergency department. Korean J Blood Transfus 2016;27:130-6 https://doi.org/10.17945/kjbt.2016.27.2.130